AI assistant
Sending…
Jazz Pharmaceuticals plc — Director's Dealing 2025
May 6, 2025
30751_dirs_2025-05-05_f5ab614d-20bd-4394-bdb3-c39d1d4fc079.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2025-05-01
Reporting Person: COZADD BRUCE C (Director, Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-05-01 | Ordinary Shares | S | 1000 | $116.35 | Disposed | 439307 | Direct |
| 2025-05-02 | Ordinary Shares | S | 500 | $120.0 | Disposed | 438807 | Direct |
Footnotes
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
More from Jazz Pharmaceuticals plc
Board/Management Information
2026
May 29
Annual Report
2026
Apr 24
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2